Synapse - Raymond Comenzo

Results (115)

A supervised analysis of gene-expression profiles of purified clonal plasma cells from patients with systemic light-chain amyloidosis (AL) who have high or low levels of serum free lambda light chains

Meeting Abstract

Comenzo, R. L.; Zhou, P.; Fleisher, M.; Olshen, A. B.
Amyloid (2006)

Fulltext@MSK | Save

Mobilization of blood stem cells with G-CSF in systemic light-chain amyloidosis: Dominant organ involvement significantly affects stem cell collection

Meeting Abstract

Comenzo, R.; Hassoun, H.; Reich, L.; Collins, N.; Nuta, A.; Chen, X. S.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Fleisher, M.; more...
Blood (2006)

Fulltext@MSK | Save

Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
Amyloid (2006)

Fulltext@MSK | Save

Accuracy of the abdominal fat pad aspirate and ancillary test results in a patient population with a high prevalence rate of amyloidosis

Meeting Abstract

Clark, B.; Lin, O.; Moreira, A.; Teruya-Feldstein, J.; Antonescu, C.; Hassoun, H.; Zhou, P.; Fleisher, M.; Comenzo, R.
Amyloid (2006)

Fulltext@MSK | Save

CD32B on clonal plasma cells in systemic light-chain amyloidosis (AL) and multiple myeloma (MM): A target for immunotherapy in both disorders and a prognostic marker in MM

Meeting Abstract

Boruchov, A.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; Rose, R.; McKenzie, S.; Maslak, P.; more...
Blood (2006)

Fulltext@MSK | Save

Pyridone 6, a Pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells

Journal Article

Pedranzini, L.; Dechow, T.; Berishaj, M.; Comenzo, R.; Zhou, P.; Azare, J.; Bornmann, W.; Bromberg, J.
Cancer Research (2006)

Fulltext@MSK | Save

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma

Journal Article

Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
British Journal of Haematology (2006)

Fulltext@MSK | Save

Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: Patients can have both monoclonal gammopathies and hereditary amyloid proteins

Journal Article

Comenzo, R. L.; Zhou, P.; Fleisher, M.; Clark, B.; Teruya-Feldstein, J.
Blood (2006)

Fulltext@MSK | Save

Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation